Biospring Partners
Overview
Biospring Partners is a growth equity firm that invests in life sciences technology . Founded in 2020, Biospring leverages its deep experience to support B2B software, tools, and biopharma services companies that are driving innovation across the life sciences industry and beyond . Biospring is well positioned to partner with life sciences technology companies that have the potential to fundamentally change how we research, diagnose and treat disease .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| cenexel clinical research | Apr 2025 | Buyout/LBO | Co-investor |
| Abzena | Mar 2022 | Private Equity | Lead |
| ixLayer | Sep 2021 | Series A Extension | - |
| Cellistic | Nov 2021 | Corporate Funding | Co-investor |
| Serán Bioscience | Sep 2026 | Growth Equity | Lead |
For institutional investors. Book with your work email.
Key People
Michelle Detwiler
Co-Founder and Managing Partner
Jivan Achreja
Operating Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Biospring Partners based?
Biospring Partners is headquartered in New York City, New York, United States.
When was Biospring Partners founded?
Biospring Partners was founded in 2020.
How many portfolio companies does Biospring Partners have?
Biospring Partners has 8 portfolio companies in Caplight's dataset.
What are some companies in Biospring Partners's portfolio?
Portfolio companies visible on Caplight include cenexel clinical research, Abzena, ixLayer, Cellistic, Serán Bioscience.
What was Biospring Partners's most recent investment shown here?
Biospring Partners's most recent investment in this portfolio sample was in Serán Bioscience in 2026.
What sectors does Biospring Partners focus on?
Biospring Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software.
What company stages does Biospring Partners focus on?
Biospring Partners typically invests at the MultiStage stage.
What is Biospring Partners's AUM?
Biospring Partners's assets under management are estimated between $250.0M and $500.0M.